Telix Pharmaceuticals | TLX - Operating Expenses

Stock Price
10.13
Daily Change
0.01 0.10%
Monthly
-7.66%
Yearly
-65.22%
Q1 Forecast
10.34

Telix Pharmaceuticals reported AUD191.9M in Operating Expenses for its fiscal semester ending in December of 2024.





Operating Expenses Change Date
Cochlear AUD 460.1M 437.1M Jun/2025
CSL USD 2.87B 2.85B Jun/2025
Integral Diagnostics AUD 219.16M 66.76M Jun/2024
Mayne Pharma AUD 103.54M 9.39M Jun/2024
Medical Developments International AUD 10.02M 9.78M Jun/2025
Mesoblast USD 56.15M 32.57M Jun/2025
Neuren Pharmaceuticals AUD 8.69M 8.72M Jun/2025
Pacific Edge NZD 25.34M 2.03M Dec/2025
Paradigm Biopharmaceuticals AUD 8.49M 2.13M Jun/2025
Polynovo AUD 27.51M 19.08M Jun/2024
PYC Therapeutics AUD 19.3M 19.28M Jun/2025
Ramsay Health Care AUD 8.72B 369.4M Jun/2025
ResMed USD 922.51M 49.28M Dec/2025
Sonic Healthcare AUD 4.23B 2.14B Dec/2024